Cargando…
Evaluation of Epstein-Barr Virus Latent Membrane Protein 2 Specific T-Cell Receptors Driven by T-Cell Specific Promoters Using Lentiviral Vector
Transduction of latent membrane protein 2 (LMP2)-specific T-cell receptors into activated T lymphocytes may provide a universal, MHC-restricted mean to treat EBV-associated tumors in adoptive immunotherapy. We compared TCR-specific promoters of distinct origin in lentiviral vectors, that is, Vβ6.7,...
Autores principales: | Yang, Dongchang, Shao, Qing, Sun, Hua, Mu, Xiaoxin, Gao, Yun, Jiang, Runqiu, Hou, Jiajie, Yao, Kun, Chen, Yun, Sun, Beicheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182378/ https://www.ncbi.nlm.nih.gov/pubmed/21969838 http://dx.doi.org/10.1155/2011/716926 |
Ejemplares similares
-
Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus
por: Kim, Kyoung-Dong, et al.
Publicado: (2020) -
Epstein–Barr virus latent genes
por: Kang, Myung-Soo, et al.
Publicado: (2015) -
Hepatitis B virus inhibition in mice by lentiviral vector mediated short hairpin RNA
por: Deng, Lei, et al.
Publicado: (2009) -
Lentiviral Vectors with Amplified Beta Cell-Specific Gene Expression
por: Shaw, Kit L., et al.
Publicado: (2009) -
Specific Marking of hESCs-Derived Hematopoietic Lineage by WAS-Promoter Driven Lentiviral Vectors
por: Muñoz, Pilar, et al.
Publicado: (2012)